Ignite Creation Date:
2024-05-05 @ 10:33 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01139333
Status:
COMPLETED
Last Update Posted:
2016-05-18
First Post:
2010-06-05
Brief Title:
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Study Overview
Official Title:
Evaluation of Mer and Axl Expression in Acute Myeloid Leukemia Patient Samples
Status:
COMPLETED
Status Verified Date:
2016-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
PURPOSE This research study is studying blood and tumor tissue samples from young patients with acute myeloid leukemia
PURPOSE This research study is studying blood and tumor tissue samples from young patients with acute myeloid leukemia
Detailed Description:
OBJECTIVES
To evaluate Mer and Axl expression in samples from pediatric patients with acute myeloid leukemia AML
To determine if abnormal expression of Mer and Axl is associated with poor clinical characteristics eg induction failure or relapse of AML in these patients
OUTLINE This is a multicenter study
Archived samples from pediatric patients with acute myeloid leukemia are analyzed for Mer and Axl expression by flow cytometry and western blot assays
To evaluate Mer and Axl expression in samples from pediatric patients with acute myeloid leukemia AML
To determine if abnormal expression of Mer and Axl is associated with poor clinical characteristics eg induction failure or relapse of AML in these patients
OUTLINE This is a multicenter study
Archived samples from pediatric patients with acute myeloid leukemia are analyzed for Mer and Axl expression by flow cytometry and western blot assays
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2011-02222 | REGISTRY | CTRP Clinical Trial Reporting Program | None |
| COG-AAML10B4 | OTHER | None | None |
| CDR0000671452 | OTHER | None | None |